369 related articles for article (PubMed ID: 33814268)
21. Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population.
Glotov OS; Savostyanov KV; Nagornova TS; Chernov AN; Fedyakov MA; Raspopova AN; Krasnoukhov KN; Danilov LG; Moiseeva NV; Kalinin RS; Tsai VV; Eismont YA; Voinova VY; Vitebskaya AV; Gurkina EY; Kuzenkova LM; Sosnina IB; Pushkov AA; Zhanin IS; Zakharova EY
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361766
[TBL] [Abstract][Full Text] [Related]
22. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
Whyte MP; Simmons JH; Moseley S; Fujita KP; Bishop N; Salman NJ; Taylor J; Phillips D; McGinn M; McAlister WH
Lancet Diabetes Endocrinol; 2019 Feb; 7(2):93-105. PubMed ID: 30558909
[TBL] [Abstract][Full Text] [Related]
23. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
[TBL] [Abstract][Full Text] [Related]
24. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.
Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T
Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183
[TBL] [Abstract][Full Text] [Related]
26. A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia.
Sugiyama Y; Watanabe T; Tajika M; Matsuhashi T; Shimura M; Fushimi T; Ichimoto K; Matsunaga A; Ebihara T; Tsuruoka T; Akiyama T; Murayama K
Orphanet J Rare Dis; 2022 Feb; 17(1):78. PubMed ID: 35197081
[TBL] [Abstract][Full Text] [Related]
27. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia.
Ogawa E; Shimura K; Yoshihashi H; Miyama S
Pediatr Neurol; 2022 May; 130():4-6. PubMed ID: 35303588
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry.
Högler W; Langman C; Gomes da Silva H; Fang S; Linglart A; Ozono K; Petryk A; Rockman-Greenberg C; Seefried L; Kishnani PS
BMC Musculoskelet Disord; 2019 Feb; 20(1):80. PubMed ID: 30764793
[TBL] [Abstract][Full Text] [Related]
29. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.
Kosnik-Infinger L; Gendron C; Gordon CB; Pan BS; van Aalst JA; Vogel TW
Neurosurg Focus; 2015 May; 38(5):E10. PubMed ID: 25929963
[TBL] [Abstract][Full Text] [Related]
30. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.
Hofmann CE; Harmatz P; Vockley J; Högler W; Nakayama H; Bishop N; Martos-Moreno GÁ; Moseley S; Fujita KP; Liese J; Rockman-Greenberg C;
J Clin Endocrinol Metab; 2019 Jul; 104(7):2735-2747. PubMed ID: 30811537
[TBL] [Abstract][Full Text] [Related]
32. Vitamin B
Whyte MP; May JD; McAlister WH; Burgener K; Cortez SR; Kreienkamp R; Castro O; Verzola R; Zavala AS; McPherson CC; Gottesman GS; Ericson KL; Coburn SP; Arbelaez AM
Bone; 2021 Sep; 150():116007. PubMed ID: 34000433
[TBL] [Abstract][Full Text] [Related]
33. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.
Whyte MP; Zhang F; Wenkert D; Mumm S; Berndt TJ; Kumar R
Bone; 2020 May; 134():115300. PubMed ID: 32112990
[TBL] [Abstract][Full Text] [Related]
34. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
[TBL] [Abstract][Full Text] [Related]
35. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.
Tenorio J; Álvarez I; Riancho-Zarrabeitia L; Martos-Moreno GÁ; Mandrile G; de la Flor Crespo M; Sukchev M; Sherif M; Kramer I; Darnaude-Ortiz MT; Arias P; Gordo G; Dapía I; Martinez-Villanueva J; Gómez R; Iturzaeta JM; Otaify G; García-Unzueta M; Rubinacci A; Riancho JA; Aglan M; Temtamy S; Hamid MA; Argente J; Ruiz-Pérez VL; Heath KE; Lapunzina P
Am J Med Genet A; 2017 Mar; 173(3):601-610. PubMed ID: 28127875
[TBL] [Abstract][Full Text] [Related]
36. Hypophosphatasia: Vitamin B
Whyte MP; Zhang F; Wenkert D; Mack KE; Bijanki VN; Ericson KL; Coburn SP
Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
[TBL] [Abstract][Full Text] [Related]
37. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.
Seefried L; Rak D; Petryk A; Genest F
Osteoporos Int; 2021 Dec; 32(12):2505-2513. PubMed ID: 34215909
[TBL] [Abstract][Full Text] [Related]
38. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
Whyte MP; McAlister WH; Mumm S; Bierhals AJ
Bone; 2019 May; 122():231-236. PubMed ID: 30825650
[TBL] [Abstract][Full Text] [Related]
39. Hypophosphatasia: Canadian update on diagnosis and management.
Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
[TBL] [Abstract][Full Text] [Related]
40. ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia.
Marini F; Masi L; Giusti F; Cianferotti L; Cioppi F; Marcucci G; Ciuffi S; Biver E; Toro G; Iolascon G; Iantomasi T; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2087-e2094. PubMed ID: 34935951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
